"Express-VAC SARS-CoV-2-ICA" Rapid Test Kit for Detection of IgG Antibodies to the Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein

The "Express-VAC SARS-CoV-2-ICA" reagent kit is intended for in vitro diagnostics of IgG antibodies to the receptor-binding domain (RBD) of the SARS-CoV-2 spike surface glycoprotein. The test uses an immunochromatographic assay method and is suitable for use with human serum, plasma, or whole (capillary) blood samples. Manufactured in accordance with TU 21.20.23-005-44090553-2021. Batch: LSVZ20L01.

Kit Configuration:

Kit No. 1:

Test cartridges – 20 pcs
Dropper bottle with buffer solution (3.0 mL) – 1 pc
Alcohol wipes (produced by LLC "Avangard", Russia, Registration Certificate RZN 2016/4620) – 20 pcs
Sterile disposable lancets (produced by HTL-STREFA S.A., Poland, Registration Certificate FSZ 2009/04308) – 20 pcs
Plastic sample transfer pipettes – 20 pcs
Certificate (passport) – 1 pc
Instructions for use – 1 pc

Kit No. 2:

Test cartridge – 1 pc
Dropper bottle with buffer solution (3.0 mL) – 1 pc
Alcohol wipe (LLC "Avangard", Russia, RZN 2016/4620) – 1 pc
Sterile disposable lancet (HTL-STREFA S.A., Poland, FSZ 2009/04308) – 1 pc
Plastic sample transfer pipette – 1 pc
Certificate (passport) – 1 pc
Instructions for use – 1 pc

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, "Express-VAC SARS-CoV-2-ICA" Rapid Test Kit for Detection of IgG Antibodies to the Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Back